Predictive Factors and Autonomy Level Change

Recruiting N/A Interventional Study
Memory Impairment
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
10,860 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients who undergo a medical visit in the Memory Clinic for the 1st time * Patients living at home or in housing * Patients with memory impairment, at all stage of the disease Exclusion Criteria: * Patients in institution * Patients under legal protection * Patients with a…
Contacts

Pierre Krolak-Salmon, Professor

(0)4 72 43 20 50

pierre.krolak-salmon@chu-lyon.fr

CONTACT

Virginie Dauphinot, Doctor

(0)4 72 43 20 50

virginie.dauphinot@chu-lyon.fr

CONTACT